Breaking News Instant updates and real-time market news.

MAS

Masco

$57.36 /

+0.92 (+1.63%)

07:08
02/09/21
02/09
07:08
02/09/21
07:08

Masco to boost dividend to 94c per share in Q2, approves new $2B repurchase pact

Masco's Board of Directors announced its intention to increase the Company's annual dividend to 94c per share from 56c per share, a 68% increase, beginning in the second quarter of 2021. The Board also approved a new $2B share repurchase authorization effective February 10, replacing the existing authorization. "The anticipated dividend increase we've announced today, along with the new $2B share repurchase authorization, underscores our strong financial position and the Board's confidence in our future," concluded Allman.

  • 09

    Feb

MAS Masco
$57.36 /

+0.92 (+1.63%)

01/13/21 BMO Capital
Masco initiated with a Market Perform at BMO Capital
01/04/21 Jefferies
Masco downgraded to Hold on tough comps at Jefferies
01/04/21 Jefferies
Masco downgraded to Hold from Buy at Jefferies
12/18/20 Barclays
Masco downgraded to Equal Weight from Overweight at Barclays

TODAY'S FREE FLY STORIES

Earnings
Tabula Rasa HealthCare sees Q3 revenue $86M-$90M, consensus $88.56M » 17:16
08/05/21
08/05
17:16
08/05/21
17:16
TRHC

Tabula Rasa HealthCare

$37.47 /

-1.885 (-4.79%)

Sees Q3 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TRHC Tabula Rasa HealthCare
$37.47 /

-1.885 (-4.79%)

TRHC Tabula Rasa HealthCare
$37.47 /

-1.885 (-4.79%)

06/03/21 Truist
Tabula Rasa HealthCare price target raised to $47 from $42 at Truist
05/28/21 Baird
Baird starts Tabula Rasa HealthCare with Outperform amid low expectations
05/27/21 Baird
Tabula Rasa HealthCare initiated with an Outperform at Baird
05/07/21 Piper Sandler
Tabula Rasa price target raised to $45 from $41 at Piper Sandler
TRHC Tabula Rasa HealthCare
$37.47 /

-1.885 (-4.79%)

Earnings
Vir Biotechnology reports Q2 EPS 46c, consensus (48c) » 17:16
08/05/21
08/05
17:16
08/05/21
17:16
VIR

Vir Biotechnology

$37.64 /

+0.385 (+1.03%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VIR Vir Biotechnology
$37.64 /

+0.385 (+1.03%)

VIR Vir Biotechnology
$37.64 /

+0.385 (+1.03%)

06/03/21 Baird
Vir Biotechnology assumed with a Neutral at Baird
05/27/21 Piper Sandler
Xencorc royalty revenue streams growing, says Piper Sandler
03/11/21 Needham
Vir Biotechnology price target raised to $80 from $75 at Needham
03/08/21 H.C. Wainwright
Vir Biotechnology price target raised to $135 from $125 at H.C. Wainwright
VIR Vir Biotechnology
$37.64 /

+0.385 (+1.03%)

Earnings
Beacon Roofing raises FY21 adjusted EBITDA view to $635M-$650M » 17:15
08/05/21
08/05
17:15
08/05/21
17:15
BECN

Beacon Roofing

$54.18 /

+0.7 (+1.31%)

Previous view…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BECN Beacon Roofing
$54.18 /

+0.7 (+1.31%)

BECN Beacon Roofing
$54.18 /

+0.7 (+1.31%)

07/15/21 Wells Fargo
Beacon Roofing initiated with an Equal Weight at Wells Fargo
07/15/21 Baird
Beacon Roofing price target raised to $66 from $65
07/15/21 Baird
Beacon Roofing price target raised to $66 from $65
05/07/21 Truist
Beacon Roofing price target raised to $68 from $49 at Truist
BECN Beacon Roofing
$54.18 /

+0.7 (+1.31%)

BECN Beacon Roofing
$54.18 /

+0.7 (+1.31%)

Earnings
National Fuel reports Q3 adjusted EPS 93c, consensus 88c » 17:15
08/05/21
08/05
17:15
08/05/21
17:15
NFG

National Fuel

$51.97 /

+0.13 (+0.25%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NFG National Fuel
$51.97 /

+0.13 (+0.25%)

NFG National Fuel
$51.97 /

+0.13 (+0.25%)

04/27/21 JPMorgan
National Fuel initiated with a Neutral at JPMorgan
03/23/21 Goldman Sachs
National Fuel assumed with a Neutral at Goldman Sachs
09/24/20 Goldman Sachs
National Fuel initiated with a Neutral at Goldman Sachs
08/12/20 BofA
National Fuel initiated with a Buy at BofA
NFG National Fuel
$51.97 /

+0.13 (+0.25%)

Earnings
Tabula Rasa HealthCare reports Q2 adjusted EPS (1c), consensus 0c » 17:14
08/05/21
08/05
17:14
08/05/21
17:14
TRHC

Tabula Rasa HealthCare

$37.47 /

-1.885 (-4.79%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TRHC Tabula Rasa HealthCare
$37.47 /

-1.885 (-4.79%)

TRHC Tabula Rasa HealthCare
$37.47 /

-1.885 (-4.79%)

06/03/21 Truist
Tabula Rasa HealthCare price target raised to $47 from $42 at Truist
05/28/21 Baird
Baird starts Tabula Rasa HealthCare with Outperform amid low expectations
05/27/21 Baird
Tabula Rasa HealthCare initiated with an Outperform at Baird
05/07/21 Piper Sandler
Tabula Rasa price target raised to $45 from $41 at Piper Sandler
TRHC Tabula Rasa HealthCare
$37.47 /

-1.885 (-4.79%)

Conference/Events
Morgan Stanley strategist to hold an analyst/industry conference call » 17:14
08/05/21
08/05
17:14
08/05/21
17:14

US Public Policy &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Earnings
Cardiff Oncology reports Q2 EPS (17c), consensus (15c) » 17:14
08/05/21
08/05
17:14
08/05/21
17:14
CRDF

Cardiff Oncology

$5.15 /

+0.14 (+2.79%)

Reports Q2 revenue $68K,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRDF Cardiff Oncology
$5.15 /

+0.14 (+2.79%)

CRDF Cardiff Oncology
$5.15 /

+0.14 (+2.79%)

02/11/21 Piper Sandler
Piper says Cardiff Oncology mCRPC opportunity 'more interesting' after data
10/22/20
Fly Intel: Top five analyst initiations
10/22/20 H.C. Wainwright
Cardiff Oncology initiated with a Buy at H.C. Wainwright
10/21/20 Maxim
Cardiff Oncology price target raised to $20 from $14 at Maxim
CRDF Cardiff Oncology
$5.15 /

+0.14 (+2.79%)

  • 30
    Sep
Earnings
Beacon Roofing sees Q4 revenue growth up mid-single digits, consensus $1.92B » 17:14
08/05/21
08/05
17:14
08/05/21
17:14
BECN

Beacon Roofing

$54.18 /

+0.7 (+1.31%)

Sees Q4 gross margins…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BECN Beacon Roofing
$54.18 /

+0.7 (+1.31%)

BECN Beacon Roofing
$54.18 /

+0.7 (+1.31%)

07/15/21 Wells Fargo
Beacon Roofing initiated with an Equal Weight at Wells Fargo
07/15/21 Baird
Beacon Roofing price target raised to $66 from $65
07/15/21 Baird
Beacon Roofing price target raised to $66 from $65
05/07/21 Truist
Beacon Roofing price target raised to $68 from $49 at Truist
BECN Beacon Roofing
$54.18 /

+0.7 (+1.31%)

BECN Beacon Roofing
$54.18 /

+0.7 (+1.31%)

Earnings
Magnite sees Q3 revenue $112M-$116M, consensus $107.1M » 17:13
08/05/21
08/05
17:13
08/05/21
17:13
MGNI

Magnite

$30.70 /

+1.08 (+3.65%)

Q3 Revenue ex-TAC…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MGNI Magnite
$30.70 /

+1.08 (+3.65%)

MGNI Magnite
$30.70 /

+1.08 (+3.65%)

07/13/21 Stifel
Tremor International initiated with a Buy at Stifel
07/02/21 Craig-Hallum
Craig-Hallum says Magnite SpringServe deal more consequential than price implies
06/25/21 Macquarie
Google cookie delay removes near-term overhang on adtech, says Macquarie
06/11/21 Stephens
Magnite partnerships can help accelerate shift in spend to CTV, says Stephens
MGNI Magnite
$30.70 /

+1.08 (+3.65%)

MGNI Magnite
$30.70 /

+1.08 (+3.65%)

MGNI Magnite
$30.70 /

+1.08 (+3.65%)

Earnings
Ritchie Bros. reports Q2 EPS 55c, consensus 61c » 17:13
08/05/21
08/05
17:13
08/05/21
17:13
RBA

Ritchie Bros.

$59.50 /

+1.12 (+1.92%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RBA Ritchie Bros.
$59.50 /

+1.12 (+1.92%)

RBA Ritchie Bros.
$59.50 /

+1.12 (+1.92%)

05/12/21 National Bank
Ritchie Bros. downgraded to Sector Perform on valuation at National Bank
05/11/21 National Bank
Ritchie Bros. downgraded to Sector Perform from Outperform at National Bank
04/21/21 OTR Global
Ritchie Bros. downgraded to Mixed from Positive at OTR Global
02/24/21
Fly Intel: Top five analyst upgrades
RBA Ritchie Bros.
$59.50 /

+1.12 (+1.92%)

Earnings
Kura Oncology reports Q2 EPS (51c), consensus (49c) » 17:12
08/05/21
08/05
17:12
08/05/21
17:12
KURA

Kura Oncology

$18.33 /

+0.71 (+4.03%)

Cash, cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KURA Kura Oncology
$18.33 /

+0.71 (+4.03%)

KURA Kura Oncology
$18.33 /

+0.71 (+4.03%)

05/04/21 Credit Suisse
Kura Oncology assumed with an Outperform at Credit Suisse
04/26/21 Credit Suisse
Kura Oncology assumed with an Outperform at Credit Suisse
02/24/21 Piper Sandler
Kura Oncology price target lowered to $30 from $34 at Piper Sandler
02/24/21 H.C. Wainwright
H.C. Wainwright trims Kura Oncology price target to $43 after Q4 report
KURA Kura Oncology
$18.33 /

+0.71 (+4.03%)

  • 09
    Dec
KURA Kura Oncology
$18.33 /

+0.71 (+4.03%)

Earnings
PHX Minerals reports Q2 EPS (5c), consensus 4c » 17:12
08/05/21
08/05
17:12
08/05/21
17:12
PHX

PHX Minerals

$2.89 /

+0.04 (+1.40%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PHX PHX Minerals
$2.89 /

+0.04 (+1.40%)

PHX PHX Minerals
$2.89 /

+0.04 (+1.40%)

05/14/21 Seaport Global
PHX Minerals initiated with a Buy at Seaport Global
05/03/21
Fly Intel: Top five analyst initiations
05/03/21 Northland
PHX Minerals initiated with an Outperform at Northland
10/08/20 Stifel
Panhandle Oil & Gas initiated with a Buy at Stifel
PHX PHX Minerals
$2.89 /

+0.04 (+1.40%)

  • 16
    Apr
  • 28
    Aug
PHX PHX Minerals
$2.89 /

+0.04 (+1.40%)

Hot Stocks
Trian's Peltz to conclude service on P&G's board at end of term » 17:11
08/05/21
08/05
17:11
08/05/21
17:11
PG

Procter & Gamble

$142.50 /

+0.08 (+0.06%)

The Procter & Gamble…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PG Procter & Gamble
$142.50 /

+0.08 (+0.06%)

PG Procter & Gamble
$142.50 /

+0.08 (+0.06%)

08/02/21 Truist
Procter & Gamble price target raised to $145 from $140 at Truist
08/02/21 Morgan Stanley
Procter & Gamble price target raised to $160 from $155 at Morgan Stanley
08/02/21 RBC Capital
Procter & Gamble price target raised to $139 from $130 at RBC Capital
08/02/21 Credit Suisse
Procter & Gamble price target raised to $145 from $135 at Credit Suisse
PG Procter & Gamble
$142.50 /

+0.08 (+0.06%)

PG Procter & Gamble
$142.50 /

+0.08 (+0.06%)

PG Procter & Gamble
$142.50 /

+0.08 (+0.06%)

PG Procter & Gamble
$142.50 /

+0.08 (+0.06%)

Earnings
Pembina Pipeline sees FY21 adjusted EBITDA C$3.3B-C$3.4B  17:11
08/05/21
08/05
17:11
08/05/21
17:11
PBA

Pembina Pipeline

$32.54 /

-0.03 (-0.09%)

 
ShowHide Related Items >><<
PBA Pembina Pipeline
$32.54 /

-0.03 (-0.09%)

PBA Pembina Pipeline
$32.54 /

-0.03 (-0.09%)

07/28/21 BMO Capital
Pembina Pipeline resumed with a Market Perform at BMO Capital
06/18/21 CIBC
Pembina Pipeline upgraded to Outperformer from Neutral at CIBC
06/16/21 National Bank
Pembina Pipeline price target raised to C$40 from C$39 at National Bank
05/10/21 RBC Capital
Pembina Pipeline price target raised to C$42 from C$40 at RBC Capital
PBA Pembina Pipeline
$32.54 /

-0.03 (-0.09%)

PBA Pembina Pipeline
$32.54 /

-0.03 (-0.09%)

Earnings
Harpoon Therapeutics reports Q2 EPS (52c), consensus (43c) » 17:11
08/05/21
08/05
17:11
08/05/21
17:11
HARP

Harpoon Therapeutics

$9.90 /

+0.07 (+0.71%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HARP Harpoon Therapeutics
$9.90 /

+0.07 (+0.71%)

HARP Harpoon Therapeutics
$9.90 /

+0.07 (+0.71%)

07/12/21 Roth Capital
Roth adds more 'SMID-cap' names to second half top picks
06/08/21
Fly Intel: Top five analyst downgrades
06/08/21 Citi
Harpoon Therapeutics downgraded to Neutral from Buy at Citi
06/07/21 Roth Capital
Harpoon prostate cancer data 'very encouraging,' says Roth Capital
HARP Harpoon Therapeutics
$9.90 /

+0.07 (+0.71%)

  • 07
    Jan
Earnings
Pembina Pipeline reports Q2 EPS C$0.39 vs, C$0.40 a year ago » 17:11
08/05/21
08/05
17:11
08/05/21
17:11
PBA

Pembina Pipeline

$32.54 /

-0.03 (-0.09%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PBA Pembina Pipeline
$32.54 /

-0.03 (-0.09%)

PBA Pembina Pipeline
$32.54 /

-0.03 (-0.09%)

07/28/21 BMO Capital
Pembina Pipeline resumed with a Market Perform at BMO Capital
06/18/21 CIBC
Pembina Pipeline upgraded to Outperformer from Neutral at CIBC
06/16/21 National Bank
Pembina Pipeline price target raised to C$40 from C$39 at National Bank
05/10/21 RBC Capital
Pembina Pipeline price target raised to C$42 from C$40 at RBC Capital
PBA Pembina Pipeline
$32.54 /

-0.03 (-0.09%)

PBA Pembina Pipeline
$32.54 /

-0.03 (-0.09%)

Earnings
LiveRamp sees FY22 revenue about $522M, consensus $509M  17:10
08/05/21
08/05
17:10
08/05/21
17:10
RAMP

LiveRamp

$38.85 /

+0.15 (+0.39%)

 
ShowHide Related Items >><<
RAMP LiveRamp
$38.85 /

+0.15 (+0.39%)

RAMP LiveRamp
$38.85 /

+0.15 (+0.39%)

07/15/21 Susquehanna
LiveRamp well positioned to capture CTV opportunity, says Susquehanna
07/15/21 Susquehanna
LiveRamp well positioned to capture CTV opportunity, says Susquehanna
06/25/21 Macquarie
Google cookie delay removes near-term overhang on adtech, says Macquarie
06/11/21 Morgan Stanley
LiveRamp news 'incrementally negative for the stock,' says Morgan Stanley
RAMP LiveRamp
$38.85 /

+0.15 (+0.39%)

  • 10
    Feb
RAMP LiveRamp
$38.85 /

+0.15 (+0.39%)

Earnings
Floor & Decor sees FY21 CapEx $455M-$475M » 17:10
08/05/21
08/05
17:10
08/05/21
17:10
FND

Floor & Decor

$127.00 /

+1.475 (+1.18%)

Sees FY21 tax rate…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FND Floor & Decor
$127.00 /

+1.475 (+1.18%)

FND Floor & Decor
$127.00 /

+1.475 (+1.18%)

07/20/21 Wolfe Research
Mister Car Wash initiated with an Outperform at Wolfe Research
06/03/21 Jefferies
Floor & Decor price target raised to $136 from $133 at Jefferies
05/18/21 Credit Suisse
Floor & Decor assumed with an Outperform at Credit Suisse
05/07/21 Barclays
Floor & Decor price target raised to $125 from $110 at Barclays
FND Floor & Decor
$127.00 /

+1.475 (+1.18%)

  • 11
    Aug
FND Floor & Decor
$127.00 /

+1.475 (+1.18%)

Earnings
LiveRamp sees Q2 revenue $124M, consensus $121.7M  17:10
08/05/21
08/05
17:10
08/05/21
17:10
RAMP

LiveRamp

$38.85 /

+0.15 (+0.39%)

 
ShowHide Related Items >><<
RAMP LiveRamp
$38.85 /

+0.15 (+0.39%)

RAMP LiveRamp
$38.85 /

+0.15 (+0.39%)

07/15/21 Susquehanna
LiveRamp well positioned to capture CTV opportunity, says Susquehanna
07/15/21 Susquehanna
LiveRamp well positioned to capture CTV opportunity, says Susquehanna
06/25/21 Macquarie
Google cookie delay removes near-term overhang on adtech, says Macquarie
06/11/21 Morgan Stanley
LiveRamp news 'incrementally negative for the stock,' says Morgan Stanley
RAMP LiveRamp
$38.85 /

+0.15 (+0.39%)

  • 10
    Feb
RAMP LiveRamp
$38.85 /

+0.15 (+0.39%)

Earnings
Floor & Decor reports Q2 adjusted EPS 73c, consensus 61c » 17:10
08/05/21
08/05
17:10
08/05/21
17:10
FND

Floor & Decor

$127.00 /

+1.475 (+1.18%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FND Floor & Decor
$127.00 /

+1.475 (+1.18%)

FND Floor & Decor
$127.00 /

+1.475 (+1.18%)

07/20/21 Wolfe Research
Mister Car Wash initiated with an Outperform at Wolfe Research
06/03/21 Jefferies
Floor & Decor price target raised to $136 from $133 at Jefferies
05/18/21 Credit Suisse
Floor & Decor assumed with an Outperform at Credit Suisse
05/07/21 Barclays
Floor & Decor price target raised to $125 from $110 at Barclays
FND Floor & Decor
$127.00 /

+1.475 (+1.18%)

  • 11
    Aug
FND Floor & Decor
$127.00 /

+1.475 (+1.18%)

Earnings
LiveRamp reports Q1 EPS 9c, consensus (2c) » 17:10
08/05/21
08/05
17:10
08/05/21
17:10
RAMP

LiveRamp

$38.85 /

+0.15 (+0.39%)

Reports Q1 revenue $119M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RAMP LiveRamp
$38.85 /

+0.15 (+0.39%)

RAMP LiveRamp
$38.85 /

+0.15 (+0.39%)

07/15/21 Susquehanna
LiveRamp well positioned to capture CTV opportunity, says Susquehanna
07/15/21 Susquehanna
LiveRamp well positioned to capture CTV opportunity, says Susquehanna
06/25/21 Macquarie
Google cookie delay removes near-term overhang on adtech, says Macquarie
06/11/21 Morgan Stanley
LiveRamp news 'incrementally negative for the stock,' says Morgan Stanley
RAMP LiveRamp
$38.85 /

+0.15 (+0.39%)

  • 10
    Feb
RAMP LiveRamp
$38.85 /

+0.15 (+0.39%)

Earnings
Cellectis reports Q2 EPS (80c), consensus (73c) » 17:09
08/05/21
08/05
17:09
08/05/21
17:09
CLLS

Cellectis

$13.78 /

+0.475 (+3.57%)

Reports Q2 revenue $15M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLLS Cellectis
$13.78 /

+0.475 (+3.57%)

CLLS Cellectis
$13.78 /

+0.475 (+3.57%)

04/28/21 Guggenheim
Cellectis downgraded to Neutral on slow progress at Guggenheim
04/28/21 Guggenheim
Cellectis downgraded to Neutral from Buy at Guggenheim
03/16/21 Baird
Cellectis upgraded to Outperform from Neutral at Baird
10/15/20 Baird
Cellectis downgraded to Neutral at Baird
CLLS Cellectis
$13.78 /

+0.475 (+3.57%)

  • 16
    Dec
Earnings
Altair Engineering sees FY21 revenue $512M-518M, consensus $509.5M  17:09
08/05/21
08/05
17:09
08/05/21
17:09
ALTR

Altair Engineering

$70.90 /

+1.84 (+2.66%)

 
ShowHide Related Items >><<
ALTR Altair Engineering
$70.90 /

+1.84 (+2.66%)

ALTR Altair Engineering
$70.90 /

+1.84 (+2.66%)

07/26/21 Rosenblatt
Altair Engineering initiated with a Buy at Rosenblatt
05/14/21
Fly Intel: Top five analyst initiations
05/14/21 Goldman Sachs
Altair Engineering assumed with a Neutral at Goldman Sachs
05/07/21 William Blair
Altair upgraded to Outperform from Market Perform at William Blair
ALTR Altair Engineering
$70.90 /

+1.84 (+2.66%)

ALTR Altair Engineering
$70.90 /

+1.84 (+2.66%)

Earnings
Mirati Therapeutics reports Q2 EPS ($3.23), consensus ($2.40) » 17:09
08/05/21
08/05
17:09
08/05/21
17:09
MRTX

Mirati Therapeutics

$164.25 /

+5.92 (+3.74%)

"We continue to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRTX Mirati Therapeutics
$164.25 /

+5.92 (+3.74%)

MRTX Mirati Therapeutics
$164.25 /

+5.92 (+3.74%)

06/04/21 Citi
Mirati Therapeutics upgraded to Buy from Neutral at Citi
05/17/21
Fly Intel: Top five analyst downgrades
05/17/21 Oppenheimer
Mirati Therapeutics downgraded to Perform from Outperform at Oppenheimer
05/17/21 Oppenheimer
Mirati Therapeutics downgraded to Perform from Outperform at Oppenheimer
MRTX Mirati Therapeutics
$164.25 /

+5.92 (+3.74%)

  • 28
    Oct
MRTX Mirati Therapeutics
$164.25 /

+5.92 (+3.74%)

Earnings
Arena Pharmaceuticals reports Q2 EPS ($2.40), consensus ($2.19) » 17:08
08/05/21
08/05
17:08
08/05/21
17:08
ARNA

Arena Pharmaceuticals

$62.00 /

+2.685 (+4.53%)

"With today's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ARNA Arena Pharmaceuticals
$62.00 /

+2.685 (+4.53%)

ARNA Arena Pharmaceuticals
$62.00 /

+2.685 (+4.53%)

05/18/21 Goldman Sachs
Arena Pharmaceuticals initiated with a Buy at Goldman Sachs
04/27/21 Citi
Arena Pharmaceuticals initiated with a Buy at Citi
04/26/21 Credit Suisse
Arena Pharmaceuticals assumed with an Outperform at Credit Suisse
04/06/21 Evercore ISI
Evercore starts 'compelling' Arena spinoff Longboard at Outperform
ARNA Arena Pharmaceuticals
$62.00 /

+2.685 (+4.53%)

ARNA Arena Pharmaceuticals
$62.00 /

+2.685 (+4.53%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.